Related Experiment Video

Updated: Mar 22, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.2K

Successful continuous-flow left ventricular assist device implantation with adjuvant tricuspid valve repair for

Chih-Hsien Lee1, Jeng Wei2

  • 1Department of Cardiac Surgery, Tungs' Taichung Metro-Harbor Hospital; Department of Biological Science and Technology, National Chiao-Tung University; Department of Surgery, National Defense Medical Centre, Taiwan.

Cardiovascular Journal of Africa
|April 16, 2016
PubMed

Insights

Continuous-flow left ventricular assist devices (cf-LVADs) offer improved survival for end-stage heart failure patients. This case highlights successful cf-LVAD implantation with tricuspid valve repair in a district hospital setting.

Area of Science:

  • Cardiology
  • Medical Devices
  • Surgical Innovation

Background:

  • Rising prevalence of end-stage heart failure (HF) contrasts with limited donor heart availability.
  • Left ventricular assist devices (LVADs) are crucial for HF management, serving as bridge-to-transplant or destination therapy.
  • Continuous-flow LVADs (cf-LVADs), like HeartMate II, represent established treatment advancements.

Observation:

  • A patient with end-stage heart failure required advanced circulatory support.
  • The patient underwent implantation of a continuous-flow LVAD (cf-LVAD).
  • Adjuvant tricuspid valve repair was performed concurrently with LVAD implantation.

Findings:

  • Successful cf-LVAD implantation provided effective hemodynamic support for the end-stage HF patient.
  • The combined procedure of cf-LVAD implantation and tricuspid valve repair was successfully executed.
  • The case demonstrates the feasibility of advanced cardiac support in a general district hospital.

Implications:

  • This case underscores the potential for wider adoption of cf-LVAD technology in community hospitals.
  • Successful integration of cf-LVADs with concurrent valve repair may improve outcomes for complex HF patients.
  • Decentralizing advanced cardiac procedures could enhance accessibility to life-saving treatments for heart failure.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
533